Seminars in Diagnostic Pathology

Papers
(The H4-Index of Seminars in Diagnostic Pathology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)
ArticleCitations
COVER (PMS 180&K) (p/u from previous issue w/updates)121
EDITORIAL BOARD (p/u from previous issue)84
Pathology of hereditary renal cell carcinoma syndromes71
Cytology and small biopsy diagnosis of pancreatic ductal adenocarcinoma64
Update on selective special types of breast neoplasms: Focusing on controversies, differential diagnosis, and molecular genetic advances54
Autoimmune pancreatitis: Biopsy interpretation and differential diagnosis34
Intraoperative evaluation of sentinel lymph nodes in patients with breast cancer: A review emphasizing clinical concepts pathologists need to know31
Going out of scope: Slide-free microscopy developments in genitourinary pathology31
MASTHEAD (p/u from previous issue)27
Spectrum of atypical ductal hyperplasia (ADH) and ductal carcinoma in-situ (DCIS): Diagnostic challenges27
TABLE OF CONTENTS (p/u from previous issue w/updates)27
EDITORIAL BOARD (p/u from previous issue)23
MASTHEAD (p/u from previous issue)22
Salivary gland-like tumors of the breast: Histopathologic and genetic features with clinical implications21
Mucin-rich salivary gland tumors21
Preface: An update on superficial mesenchymal tumors: How the explosion of data translates into every day clinical practice19
Head and neck xanthogranulomatous epithelial tumors/keratin-positive giant cell-rich tumors19
The current practice of telecytology for rapid on-site evaluation (ROSE): Practical considerations and limitations17
A personalized approach to lymphoproliferations in patients with inborn errors of immunity17
Gene fusions in superficial mesenchymal neoplasms: Emerging entities and useful diagnostic adjuncts17
0.10120320320129